These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9164338)

  • 21. Losartan in post-transplant erythrocytosis.
    Conlon PJ; Smith SR; Butterly DW; Brennan DC
    Nephrol Dial Transplant; 1996 Dec; 11(12):2524-5. PubMed ID: 9017645
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
    Araki M; Kanda T; Imai S; Suzuki T; Murata K; Kobayashi I
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):61-5. PubMed ID: 7564367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.
    Parkhomenko AN; Irkin OI; Kushnir SP; Bryl ZV; Soliarik O; Shkliar LV
    Acta Cardiol; 2002 Feb; 57(1):61-3. PubMed ID: 11918155
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiproteinuric effect of Losartan in patients with chronic renal diseases.
    Zoccali C; Valvo E; Russo D; Panichi V; Zuccala' A
    Nephrol Dial Transplant; 1997 Jan; 12(1):234-5. PubMed ID: 9027813
    [No Abstract]   [Full Text] [Related]  

  • 25. ELITE study raises losartan's profile in heart failure therapy debate.
    S Afr Med J; 1997 Jun; 87 Suppl 3():C182. PubMed ID: 9254771
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined heart failure treatment with ACE inhibition and AT1-receptor blockade.
    Willenheimer R; Cline C; Erhardt L
    Eur Heart J; 1996 Nov; 17(11):1768-9. PubMed ID: 8922941
    [No Abstract]   [Full Text] [Related]  

  • 27. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
    Morrell NW
    Chest; 1997 May; 111(5):1469-70. PubMed ID: 9149625
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of losartan and captopril in ELITE II.
    Lye M
    Lancet; 2000 Sep; 356(9232):852; author reply 852-3. PubMed ID: 11022949
    [No Abstract]   [Full Text] [Related]  

  • 31. Angioedema associated with angiotensin II receptor antagonist losartan.
    Sharma PK; Yium JJ
    South Med J; 1997 May; 90(5):552-3. PubMed ID: 9160080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin receptor antagonists as a treatment for hypertension.
    MacFadyen RJ; Reid JL
    J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
    Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of losartan and captopril in ELITE II.
    Meyer FP
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.
    Pitt B
    Eur Heart J; 1997 Aug; 18(8):1197-9. PubMed ID: 9458406
    [No Abstract]   [Full Text] [Related]  

  • 36. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
    Elicio N; Bertolini S; Garbarini R; Nardiello G; Elicio A; Aimale V
    Artif Organs; 1997 Apr; 21(4):334-5. PubMed ID: 9096809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
    Eguchi K; Kario K; Shimada K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():679-84. PubMed ID: 12387069
    [No Abstract]   [Full Text] [Related]  

  • 39. Losartan in heart failure: preclinical experiences and initial clinical outcomes.
    Sweet CS; Rucinska EJ
    Eur Heart J; 1994 Dec; 15 Suppl D():139-44. PubMed ID: 7713103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.